Clinical trial
A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD
NCT00163098 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00163098 |
|---|---|
| Title | A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD |
| Official title | A Multi-Centre, Multinational, Randomized, Double-Blind, Placebo Controlled, Proof Of Concept Trial To Assess The Effects Of A Subject-Optimized Dose Of UK-369,003 On Exercise Capacity In Subjects With Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | UK-369, 003 |
| Enrollment | 136 |
| Start date | Dec 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 13, 2005 |
| Last update posted | Oct 13, 2006 |
| Countries | Argentina, Australia, Germany, India, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: